Lower levels of testing and higher positivity rates, higher rates of dangerous drug combination use, and increases in fatal and non-fatal overdoses during the coronavirus disease 2019 (COVID-19) pandemic reveal a need for more resources to address the opioid epidemic in the United States.
This KCast features Jeanne Sheffield, MD, Director of Maternal-Fetal Medicine at John Hopkins Medicine, and Aparna Sridhar, MD, MPH, an ob/gyn at UCLA Health as they discuss COVID's impact on testing, telehealth, and care accessibility.
Have payer disparities seemed to grow worse during the pandemic, especially with telehealth? Take the poll now.
The scoping review revealed target areas that require additional research, as well as a need for more variety in study designs, populations, and locations.
Some women are unable to choose noninvasive prenatal testing (NIPT), due to lack of insurance coverage, according to a pilot study in the Journal of Community Genetics.
Office of the Inspector General recommends CMS conduct targeted hospital reviews for possible upcoding violations.
Since 2012, when South Carolina's Medicaid program became the first state Medicaid program to separate payment for the immediate postpartum placement of long-acting reversible contraception (LARC) from global maternity payment, a significantly greater number of mothers are using LARC, especially among adolescents.
Diverse Voices: COVID-19 and the Health of Women, a virtual speaker series run by the NIH Office of Research on Women’s Health (ORWH), presented compiled research on sex and gender disparities during the COVID-19 pandemic. In addition to identifying issues of concern, the webinar offered actions to improve women’s health despite sex and gender disadvantages.
A narrative review identified gaps in knowledge and considerations for informing sexually transmitted infection (STI) screening guidelines and treatment to improve the health of pregnant women and children.